Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Persistent or Recurrent Endometrial Carcinoma
NCT00027690Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2002
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in endometrial carcinoma, sponsored by National Cancer Institute. Started Jun 2002; status: completed.
02
Drugs
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00027690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027690.